Lynda C Schneider MD
Clinical & Laboratory Immunology
Professor of Pediatrics, Harvard Medical School
Join to View Full Profile
300 Longwood AveBoston, MA 02115
Phone+1 617-355-6180
Fax+1 617-730-0310
Dr. Schneider is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston Children’s HospitalFellowship, Allergy and Immunology, 1987 - 1990
Mass General Brigham/Massachusetts General HospitalResidency, Pediatrics, 1983 - 1986
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1983
Certifications & Licensure
MA State Medical License 1986 - 2025
American Board of Allergy and Immunology Allergy & Immunology- American Board of Allergy and Immunology Diagnostic Laboratory Immunology
American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Boston Magazine Castle Connolly, 2010-2013
- Fellow (FAAP) American Academy of Pediatrics
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Clinical Trials
- Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders Start of enrollment: 2002 Jun 25
- Immune Response to Varicella Vaccination in Children With Atopic Dermatitis Start of enrollment: 2005 Dec 01
- Xolair Enhances Oral Desensitization in Peanut Allergic Patients Start of enrollment: 2011 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Depression and anxiety in patients with atopic dermatitis: Recognizing and addressing mental health burden.Jennifer S LeBovidge, Lynda C Schneider
Annals of Allergy, Asthma & Immunology. 2025-03-19 - Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study).Jacqueline A Pongracic, Rémi Gagnon, Gordon Sussman, Dareen Siri, Roxanne C Oriel
The Journal of Allergy and Clinical Immunology. in Practice. 2025-02-27 - Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE.Matthew Greenhawt, Deborah Albright, Sara Anvari, Nicolette Arends, Peter D Arkwright
The Journal of Allergy and Clinical Immunology. in Practice. 2025-02-14
Journal Articles
- Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children with Peanut AllergyTodd D Green, David M Fleischer, Hey Chong, R Sharon Chinthrajah, Edwin H Kim, Stacie M Jones, Robert Wood, Bruce J Lanser, Lynda Schneider, Jacqueline A Pongracic, Wa..., JAMA
- Original Article Long-Term Outcome of Peanut Oral Immunotherapy Facilitated Initially by OmalizumabDale T Umetsu, Rima Rachid, Jennifer LeBovidge, Lynda Schneider, ScienceDirect
Press Mentions
Ukko Secures $40 Million in Series B Funding Led by Leaps by Bayer to Overcome Food Allergies and SensitivitiesJanuary 27th, 2021
Baby Food Products for Early Allergen Introduction Hit MarketMarch 14th, 2018
IL-31 Pathway May Lead to New Treatments for PruritusAugust 18th, 2017- Join now to see all
Grant Support
- Immune Response To Varicella Vaccination In Subjects With Atopic DermatitisNational Center For Research Resources2007
- Genetics Of Atopic Dermatitis - Eczema Herpeticum (ADEH) StudyNational Center For Research Resources2007
- Genetic And Environmental Risk Factors In Atopic DermatitisNational Center For Research Resources2007
- Advn Biomarker Registry StudyNational Center For Research Resources2007
- Edema2:Evaluation Of Dx-88'S Effects In Mitigating Angioedema, An OPEN Label STDNational Center For Research Resources2004–2006
- Dx-88 In Hereditary AngioedemaNational Center For Research Resources2004–2005
- Vapor Heated C-1 Inhibitor Immunotherapy In HaeNational Center For Research Resources2000–2002
- Study Of Budesonide Nebulizing Suspension &Placebo In Asthmatic ChildrenNational Center For Research Resources1997–1999
- OPEN Label Extension To A Study Of Four Dose Regimens Of BudesonideNational Center For Research Resources1997–1999
- Trial Of Nebulized Budesonide For Moderate Asthma In ChildrenNational Center For Research Resources1996
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
